Carlsmed (CARL) Other Accumulated Expenses (2024 - 2026)

Carlsmed (CARL) has reported Other Accumulated Expenses for 3 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Accumulated Expenses rose 191.32% year-over-year to $1.0 million; the trailing twelve-month figure through Jun 2026 stood at $1.0 million (up 191.32% YoY), and the FY2025 full-year result was $934000.0, up 74.25% from the prior year.
• Other Accumulated Expenses grew to $1.0 million in Q2 2026 per CARL's latest filing, from $468000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $1.0 million in Q2 2026 and bottomed at $325000.0 in Q3 2025.
• Historically, Other Accumulated Expenses has averaged $610000.0 across 3 years, with a median of $502000.0 in 2024.
• The sharpest annual moves came in 2025 and 2026: Other Accumulated Expenses surged 74.25% in 2025, then jumped 191.32% in 2026.
• Over 3 years, Other Accumulated Expenses stood at $536000.0 in 2024, then surged by 74.25% to $934000.0 in 2025, then advanced by 11.35% to $1.0 million in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $1.0 million, $468000.0, and $934000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.